LISA DAVIS: Open Payments
NPI 1609246966 · FLATWOODS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$790 in 57 payments from 9 companies in 2025. Trend: 2023 $676 · 2024 $708 · 2025 $790
Food & beverage: $790
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $313 |
| PFIZER INC. | 13 | $146 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $91 |
| Novo Nordisk Inc | 4 | $75 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Exact Sciences Corporation | 2 | $31 |
| Corcept Therapeutics | 1 | $15 |
Products named: VRAYLAR, ELIQUIS, CAPLYTA, TRELEGY ELLIPTA, UBRELVY, Rybelsus, REXULTI, NURTEC ODT.
Industry payments across KY — which companies pay providers there.
